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THE HYPERLIPEMIA OF LYMPHOMA-BEARING HAMSTERSt
Greene and Harvey,' and subsequently Gershon and colleagues,'" have de-
scribed the biologic and immunologic behavior of a spontaneously arising
transplantable lymphoma of the golden hamster. This tumor, morphologi-
cally a lymphoblastic lymphoma, grows rapidly on subcutaneous transplanta-
tion, but metastasizes rarely, even though viable tumor cells may be demon-
strated in the blood by the seventh day. During his investigations, Greeneu
observed that the plasma of tumor-bearing animals was frequently milky in
appearance. The present report is concerned with a characterization of this
milkiness.
MATERIALS AND METHODS
The majority of the experiments were performed with randomly bred male Syrian
golden hamsters (Hilltop Farms, Scottdale, Pennsylvania) whose weights at the time
of receiving the tumor transplant were 60-80 grams. They were maintained on Purina
Laboratory Chow.
The tumor was maintained by serial transplantation every two to three weeks from
animals originating in Greene's laboratory. Transplantation was effected by teans of a
size 14 trocar containing a tumor fragment approximately 1 X 1 X 1 mm. inserted
subcutaneously through a small skin slit,while the animals were under a light (6.0 mg.
per 100 gram) sodium pentobarbital anesthesia.
Control animals were derived from the same shipments as the experimental animals.-
Sham operations under identical conditions yielded lipid levels similar to those of con-
trols who had not had operations. Except in one group in which serial bloods were
drawn from the heart of the intact anesthetized animal, the chest of the anesthetized
animal was opened and blood drawn directly from the heart. For serum determinations,
blood was permitted to clot in 10 X 75 mm. culture tubes, spun at 4,500 RPM in an
International Clinical Centrifuge. Blood was drawn in heparinized syringes for those
procedures requiring plasma. Unless otherwise indicated, all series of animals were
fasted for approximately 16 hours before being bled.
The serum (plasma) lipids were extracted in chloroform-methanol and analyzed for
triglycerides by either the indirect method' or by Lofland'se semiautomatic adaptation
of the direct method of Van Handel and Zilversmit.1' Cholesterol' and phospholipids as
lipid phosphorus" were also determined. Glucose was determined by autoanalyzer.
Electrophoresis was by the Quick Disc Method, using polyacrylamide gels (Canalco).
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RESULTS
Behavior of tumor
Thorough descriptions of the growth of the tumor have been given pre-
viously.`3 Our experience is comparable. Briefly, the tumor became palpable
in some animals as early as four days after transplantation. Growth was
extremely variable in rate and extent, and the tumor remained in a sub-
cutaneous location, although skin involvement with eventual ulceration has
been observed in 2 to 3 weeks. Gross evidence of metastases was not ob-
served in our animals. Splenic and hepatic enlargement were present, but
weights were not analyzed because of the variation in the amount of blood
drawn, which would be reflected in the weight of these organs.
Tumor-bearing animals developed an anemia after approximately eleven
days as manifested by the reduced size of the centrifuged clot compared
with controls.
Non-fasted animals of both sexes
Figure 1 shows the results of a preliminary study of non-fasted animals
of both sexes. In this series, animals were bled just before the tumor was
transplanted and a second bleeding was performed just prior to sacrifice on
the 12th day. All of the animals showed a rise in triglycerides, although
that of one male was within the range of normal. Results of the cholesterol
determinations were more variable and, as shown by the arrows, one male
and three females had a lower level of serum cholesterol after bearing the
tumor than before transplantation.
Because of the relative consistency found in the response of the male ani-
mals, all subsequent experiments were performed solely with males. It was
further decided that results from future series would be more significant if
the animals were bled only after fasting.
Fasted animals
Figure 2 represents a compilation of serum cholesterol and triglyceride
levels on several series of control and tumor-bearing animals. The time after
transplantation of the tumor in the latter group varied between 4 and 43
days. The control values showed less variation for the triglycerides than for
the cholesterol levels. The experimental animals exhibited a wide variation
in both cholesterol and triglyceride levels, but in both determinations the
tumor-bearing animals showed a higher average than the controls. Phospho-
lipids, like cholesterols, were moderately increased. Lipid phosphorus level
for the control animals was 7.2 ± 0.3 mg.%o and for the tumor-bearing
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FIG. 1. Serum cholesterol and triglyceride levels in non-fasted hamsters before, and
twelve days after, tumor transplantation. Each tertical line joins the cholesterol or
triglyceride concentration for one animal before and after the transplant. The post-
transplant values were higher in all except those lines broken by a V.
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animals was 9.2 +± 0.4 mg.%o. The increase in triglycerides was by far the
most striking lipid abnormality.
Time after transplantation and triglyceride levels
The serum triglyceride levels and the days after transplantation for the
same animals are shown in Figure 3. Wide variations are apparent for a
given time, including values that are within the range of the control values.
The small numbers of animals at both ends do not permit a definite con-
clusion, but suggest that a given animal is more apt to have elevated trigly-
cerides the longer he bears his tumor during the first 25 days.
Tumor weight and triglycerides
As shown in Figure 4, there was considerable variation in triglyceride
levels for a specific tumor weight. In general, however, the larger the tumor
the higher the triglycerides up to a tumor weight ofapproximately 20 grams.
Part of the variability observed might be related to the extent of necrosis of
individual tumors, but no attempt to quantitate this factor was made.
Plasmaglucose
Plasma glucose in a smaller series was 136 ± 5.3 mg.% for 10 control
animals and 80 + 7.2 mg.%o for 31 tumor-bearing animals.
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FIG. 2. Serum cholesterol and triglyceride concentration of individual control and
tumor-bearing animals. Duration of tumor ranged from 4 to 43 days.
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FIG. 3. Relation between triglyceride concentration and time since inoculation for in-
dividual animals.
Electrophoretic pattern
Eight sham-operated, fasted controls, when sacrificed 19 days ofter op-
eration, exhibited a serum lipoprotein electrophoretic pattern similar to that
of normal humans. Fourteen tumor-bearing animals were sacrificed at the
same time. Of these, one showed a normal electrophoretic pattern, two were
classified as Fredrickson and Lees1T Type IV, and the remaining eleven were
Type V. The one tumor-bearing animal with a normal pattern showed no
gross turbidity of the serum, although its tumor weighed 3.5 grams. Serum
lipid determinations were not performed on this series of animals because
of an insufficient quantity.
DISCUSSION
Male hamsters bearing the Greene lymphoma exhibit elevated serum
cholesterol, lipid phosphorus, and triglycerides as compared with control
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animals. Wide variations of values were seen, but, in general, the lipid levels
increased with size and duration of tumor, and elevation of triglycerides
was the most striking lipid abnormality. The size of viable tumor is difficult
to evaluate, however, because of varying amounts of necrosis seen in differ-
ent animals. Despite some variability of response among animals, it never-
theless appeared quite clear that an interaction between tumor and host
resulted in elevated serum lipid levels.
Begg18 has summarized the studies in his laboratory on the lipemia of rats
bearing the Walker 256 carcinoma. He demonstrated an increase in serum
fatty acids, but did not characterize the lipemia in terms of other lipid com-
ponents and did not report the lipoprotein class. The effect was most marked
when the rats were fed a high-fat diet and appeared to have "no direct rela-
tion to tumor size." A defect in the clearing mechanism was suggested as
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FIG. 4. Relation between triglyceride concentration and tumor weight for individual
animals.
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one of the factors implicated in the development of the hyperlipemia.
Posner' also studied the lipemia of Walker 256 tumor-bearing rats. He
force fed triolein-Il31 test diets and determined fat tolerance curves. He
showed that the hyperlipemia was due to impaired lipoprotein lipase. He
further concluded that the fasting hyperlipemia which he observed was due
to failure of clearance of endogenous fat derived from fat depots.
Barclay, et al.' reported an increase in low density lipoprotein Sf 0-20
(D < 1.006) and a decrease in high density lipoprotein (D < 1.125), also,
in rats bearing the Walker 256 tumor. Chemically induced tumors (9, 10
Dimethyl-1, 2-benzanthracene) also were associated with a decrease in high
density lipoproteins in rats. The opposite finding of increased high density
lipoproteins occurred in rats bearing transplanted Morris Hepatoma 7777
(Narayan and Morris') and is probably a specific effect of liver involve-
ment.
In none of the accounts were triglyceride levels measured nor was there
an effort made to distinguish exogenous from endogenous triglyceridemia,
although both Begg and Posner suggested that alimentary lipemia was the
chief factor.
Our finding of a Fredrickson and Lees Type V lipoproteinemia17 in lym-
phoma-bearing hamsters is consistent with the finding of exogenous lipemia
in Walker 256 tumor-bearing rats, and also suggests a defect in the clearing
of exogenous fat. The pre beta band in the present study suggests that the
defect also involves clearing of endogenous fat.
Intolerance to exogenous and probably also endogenous triglyceride may
be caused by an inherited deficiency of adipose tissue lipoprotein lipase, the
enzyme responsible for the removal of triglycerides by adipose tissue. An
acquired exogenous lipemia may be caused by lack of insulin.' The low
blood sugars of the present study rule out any association with diabetes.
Glueck, et al." have recently described an acquired exogenous lipemia
associated with abnormal immune globulins in two patients with lupus
erythematosus and in one patient with a lymphoblastic lymphoma. In all
three, impaired lipoprotein lipase activity was due to inactivation of heparin
by binding to the abnormal globulins. The physiologic role of heparin in
promoting lipoprotein lipase activity was thus inhibited.
The similarities of the histological classification of tumor and lipoprotein
type of Glueck's lymphoma patient to those of our hamsters indicates that
the latter may also be an example of lipemia associated with immune globu-
lins. A change in the immune mechanism has been demonstrated in animals
bearing the Greene tumor. Greene and Harvey' observed profound resistance
to metastasis and refractoriness to re-inoculation with the same tumor so
long as the original tumor was present. This state of immunity has been
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shown by Gershon, et al. to be cell-mediated7 but humoral antibodies were
also demonstrated by immunofluorescence as increased gamma globulins in
the spleen.'
These various human and animal studies together'with reports of lipemia
in humans with cancer' and with certain gram negative infections' suggest
that lipemia may be a widely occurring biologic phenomenon resulting from
elevation of certain immune globulins.
An alternative explanation to that of binding of heparin by immune
globulins is the binding of lipids by immune globulins (Beaumont"). What-
ever the mechanism, the diversion of circulating triglycerides away' from
adipose tissue could be of profound physiological significance.
SUMMARY
The serum milkiness that accompanied the growth of a non-metastasizing,
spontaneously arising lymphoma in hamsters was due to elevated serum
lipids. Serum cholesterol, phosphorus, and triglycerides were all elevated in
both fed and fasted animals, but the elevation of triglycerides was more
pronounced.and more consistent than the others. Although there was con-
siderable variation in individual animals,, in general triglyceride levels in-
creased with increasing time after transplantation during the first 25 days.
The lipoprotein electrophoretic pattern was Type V, which suggests that
defects in clearing both exogenous and endogenous fat'may be' responsible
for the hyperlipemia.
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